In vitro pharmacodynamic properties of MK-0991 determined by time-kill methods

被引:127
作者
Ernst, EJ
Klepser, ME
Ernst, ME
Messer, SA
Pfaller, MA
机构
[1] Univ Iowa Hosp & Clin, Coll Pharm, Iowa City, IA 52242 USA
[2] Univ Iowa Hosp & Clin, Dept Pathol, Iowa City, IA 52242 USA
关键词
D O I
10.1016/S0732-8893(98)00130-8
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
MK-0991 has demonstrated activity against a variety of fungal pathogens., we evaluated the MIC endpoint for MK-0991 by reading the endpoint using three methods and comparing these results with minimum fungicidial concentrations and electron micrographs, The concentration that resulted in 80% inhibition of fungal growth compared with control, similar to the endpoint for the azole antifungal agents, provided the most consistent results. Additionally, we investigated the time-kill properties of this agent agonist two isolated each of Candida albicans, Candida glabrata and Candida tropicalis at concentrations ranging from 0.125 x MIC to 16 x MIC. Kill curves were performed using RPMI buffered with morpholine propanesulfonic acid as growth media. Samples were obtained at predetermined time points over 24 h and plated for colony counting. Fungicidal activity was observed with one isolate of C. albicans, two isolates of C. glabrata, and one isolate of C. tropicalis. MK-0991 displayed concentration-dependent activity, which was fungicidal or fungistatic depending on the isolate tested. (C) 1999 Elsevier Science Inc.
引用
收藏
页码:75 / 80
页数:6
相关论文
共 14 条
  • [1] Evaluation of the echinocandin antifungal MK-0991 (L-743,872): Efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis
    Abruzzo, GK
    Flattery, AM
    Gill, CJ
    Kong, L
    Smith, JG
    Pikounis, VB
    Balkovec, JM
    Bouffard, AF
    Dropinski, JF
    Rosen, H
    Kropp, H
    Bartizal, K
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) : 2333 - 2338
  • [2] In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)
    Bartizal, K
    Gill, CJ
    Abruzzo, GK
    Flattery, AM
    Kong, L
    Scott, PM
    Smith, JG
    Leighton, CE
    Bouffard, A
    Dropinski, JF
    Balkovec, J
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) : 2326 - 2332
  • [3] In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds
    DelPoeta, M
    Schell, WA
    Perfect, JR
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (08) : 1835 - 1836
  • [4] Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro
    Franzot, SP
    Casadevall, A
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (02) : 331 - 336
  • [5] Treatment of murine disseminated candidiasis with L-743,872
    Graybill, JR
    Najvar, LK
    Luther, MF
    Fothergill, AW
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (08) : 1775 - 1777
  • [6] Treatment of murine Candida krusei or Candida glabrata infection with L-743,872
    Graybill, JR
    Bocanegra, R
    Luther, M
    Fothergill, A
    Rinaldi, MJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (09) : 1937 - 1939
  • [7] Treatment of histoplasmosis with MK-991 (L-743,872)
    Graybill, JR
    Najvar, LK
    Montalbo, EM
    Barchiesi, FJ
    Luther, MF
    Rinaldi, MG
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (01) : 151 - 153
  • [8] Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872)
    Hajdu, R
    Thompson, R
    Sundelof, JG
    Pelak, BA
    Bouffard, FA
    Dropinski, JF
    Kropp, H
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) : 2339 - 2344
  • [9] Influence of test conditions on antifungal time-kill curve results: Proposal for standardized methods
    Klepser, ME
    Ernst, EJ
    Lewis, RE
    Ernst, ME
    Pfaller, MA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (05) : 1207 - 1212
  • [10] Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans
    Klepser, ME
    Wolfe, EJ
    Jones, RN
    Nightingale, CH
    Pfaller, MA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (06) : 1392 - 1395